Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

13,800

Employees13,800

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

13,800

Employees13,800

ZTS Key Statistics

Market cap

65.68B

Market cap65.68B

Price-Earnings ratio

25.21

Price-Earnings ratio25.21

Dividend yield

1.32%

Dividend yield1.32%

Average volume

4.24M

Average volume4.24M

High today

$149.00

High today$149.00

Low today

$146.90

Low today$146.90

Open price

$147.83

Open price$147.83

Volume

3.52M

Volume3.52M

52 Week high

$200.33

52 Week high$200.33

52 Week low

$139.70

52 Week low$139.70

ZTS News

Seeking Alpha 3d

Zoetis raises 2025 organic operational revenue growth guidance to up to 8% while advancing key franchises

Earnings Call Insights Zoetis raises 2025 organic operational revenue growth guidance to up to 8% while advancing key franchises Aug. 05, 2025 12:21 PM ET Zoeti...

Reuters 3d

Animal healthcare firm Zoetis raises annual forecast on strong pet product demand - Reuters

...

Analyst ratings

80%

of 20 ratings

Buy

80%

Hold

20%

Sell

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.